Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
ernesto.maddaloni@uniroma1.it
Ernesto Maddaloni
Professore Associato
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
ernesto.maddaloni@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status
THE AMERICAN JOURNAL OF CARDIOLOGY
2022
Development of a clinical risk score to predict death in patients with COVID-19
DIABETES/METABOLISM RESEARCH AND REVIEWS
2022
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
2022
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective
DIABETES, OBESITY AND METABOLISM
2022
Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes
DIABETES RESEARCH AND CLINICAL PRACTICE
2022
Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment. A Pilot Study
JOURNAL OF CLINICAL MEDICINE
2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study
ANTIOXIDANTS
2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I
DIABETES/METABOLISM RESEARCH AND REVIEWS
2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA
FRONTIERS IN ENDOCRINOLOGY
2022
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis
CIRCULATION RESEARCH
2022
Adult-onset autoimmune diabetes
NATURE REVIEWS. DISEASE PRIMERS
2022
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study
DIABETIC MEDICINE
2021
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome
INTERNAL AND EMERGENCY MEDICINE
2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism
ENDOCRINE
2021
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study
DIABETES, OBESITY AND METABOLISM
2021
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease
FRONTIERS IN PHARMACOLOGY
2021
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes
DIABETES RESEARCH AND CLINICAL PRACTICE
2021
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis
INTERNAL AND EMERGENCY MEDICINE
2021
« prima
< precedente
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Correlazione tra Fragilità Ossea e Neuropatia Autonomica nel Diabete Autoimmune
Gruppi di ricerca
Intervento farmacologico inibente la differenziazione delle cellule mieloidi verso un fenotipo calcificante
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
Molecular and pathophysiological heterogeneity of autoimmune diabetes: implications for precision medicine
Synergies anchoring to gravity (SynErg): a novel test to diagnose risk of falls in type 2 diabetes patients
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma